Back to search
Idiopathic Interstitial Pneumonias / Hypertension,Pulmonary
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Idiopathic Interstitial Pneumonias / Hypertension,Pulmonary trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Idiopathic Interstitial Pneumonias / Hypertension,Pulmonary trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study will evaluate whether participants with serious lung diseases such as idiopathic pulmonary fibrosis, sarcoidosis, and pulmonary hypertension who use…
This study assesses the safety and efficacy of bardoxolone methyl relative to placebo in patients with pulmonary hypertension to determine the recommended dose…
This study analyzes patients who underwent lung transplantation at the First Affiliated Hospital of Zhejiang University from 2017 to 2024, focusing on anesthesi…
To evaluate the efficacy and safety of 26-weeks of treatment with riociguat vs. placebo in patients with symptomatic PH (pulmonary hypertension) associated with…
Over time, patients with fibrosing or interstitial lung disease (ILD) can develop high lung blood pressures (pulmonary hypertension), and this is associated wit…